Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion (Q73185913)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 November 1999
edit
Language Label Description Also known as
English
Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion
scientific article published on 01 November 1999

    Statements

    title
    Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    10562982
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10562982%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    2 November 2019

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q73185913&oldid=1984866486"